In the article, What Jason Hope Says About New Longevity Research, Leena Boor writes about Jason Hope’s reserved encouragement for the future of stem cell regeneration. Published by the website, www.Healthtechzone.com, on March 11, 2020, the successful entrepreneur expressed his concern for quick startups touting miracle cures and anti-aging formulas for the elderly without the appropriate length of time invested in research, testing, and development. Jason Hope himself is a long-time investor in the medical community. He shares high hopes for the eventual medical treatment and anti-aging ability of stem cell regeneration. 

Currently, his philanthropic efforts in this area focus on the preventive process of disease along with improving the quality of life regenerative stem cell usage have the potential to provide. His concern is mainly related to obtaining the medical community’s approval before involving public distribution. Without such backing, Jason Hope fears quick start-ups will be promoting life-altering claims that are just not true. He would like to see the ability of stem-cell research backed by the medical community with the correct measure of scientific discovery noted.

Jason Hope is an entrepreneur with a long-term philanthropic investment in the biotech community. His relationship with SENS (Strategies for Engineered Negligible Senescence) involves creating an answer to preventing the disease in the first place as opposed to treatment of the same disease. Scientists involved with SENS are focused on stem cell intervention. Jason Hope continues to back the progress of stem cell research and its positive medical abilities. His allegiance to following the correct procedures in scientific discovery does not delay his support of stem cell research. His allegiance to offering the public a medically supported option that has been fully discussed in the scientific community is without fail.